The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Chronic Kidney Disease and Cognitive Impairment: A Systematic Review and Meta-Analysis
Abstract
Background: Chronic kidney disease (CKD) has emerged as a possible new risk factor of cognitive impairment and dementia, but results of studies remain conflicting. Methods: A systematic literature research of electronic databases (MEDLINE, Cochrane Library and Goggle Scholar covering the period from 1980 to January 2012) and meta-analysis of relevant cross-sectional and longitudinal studies were conducted to assess the association of CKD and cognitive decline. Results: Most cross-sectional and longitudinal studies suggest an association between cognitive impairment and CKD. Meta-analysis of cross-sectional and longitudinal studies comprising 54,779 participants yielded an association of cognitive decline in patients with CKD compared with patients without CKD (OR 1.65, 95% CI 1.32–2.05; p < 0.001, and OR 1.39, 95% CI 1.15–1.68; p < 0.001, respectively). Conclusion: This is the first meta-analysis assessing the impact of CKD on cognitive decline. Our results suggest CKD being a significant and independent somatic risk factor in the development of cognitive decline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 3,850
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,666
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
Pfeffer, M. A., Burdmann, E. A., Chen, C.-Y., Cooper, M. E., de Zeeuw, D., Eckardt, K.-U., Feyzi, J. M., Ivanovich, P., Kewalramani, R., Levey, A. S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907845 · Cited by 2,096
Petersen, R. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp0910237 · Cited by 1,289
Vascular risk factors for Alzheimer’s disease:
Breteler, M. M. B. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00110-4 · Cited by 664
Kurella, M., Chertow, G. M., Fried, L. F., Cummings, S. R., Harris, T., Simonsick, E., Satterfield, S., Ayonayon, H., & Yaffe, K. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010005 · Cited by 458
Kurella Tamura, M., Wadley, V., Yaffe, K., McClure, L. A., Howard, G., Go, R., Allman, R. M., Warnock, D. G., & McClellan, W. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.05.004 · Cited by 388
Seliger, S. L., Siscovick, D. S., Stehman-Breen, C. O., Gillen, D. L., Fitzpatrick, A., Bleyer, A., & Kuller, L. H. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000131529.60019.fa · Cited by 343
Quality of sleep and health-related quality of life in haemodialysis patients
Iliescu, E. A. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/18.1.126 · Cited by 335
Cited by
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
Hill, N. R., Fatoba, S. T., Oke, J. L., Hirst, J. A., O’Callaghan, C. A., Lasserson, D. S., & Hobbs, F. D. R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158765 · Cited by 4,030
Webster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32064-5 · Cited by 3,842
Deckers, K., van Boxtel, M. P. J., Schiepers, O. J. G., de Vugt, M., Muñoz Sánchez, J. L., Anstey, K. J., Brayne, C., Dartigues, J.-F., Engedal, K., Kivipelto, M., et al. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4245 · Cited by 534
Stroke and cerebrovascular diseases in patients with chronic kidney disease
Toyoda, K., & Ninomiya, T. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70026-2 · Cited by 346
Cardiovascular risk factors and future risk of Alzheimer’s disease
de Bruijn, R. F., & Ikram, M. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0130-5 · Cited by 322
Neuropsychiatric Disorders in Chronic Kidney Disease
Simões e Silva, A. C., Miranda, A. S., Rocha, N. P., & Teixeira, A. L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00932 · Cited by 124
Cognitive function and associated factors among older people in Taiwan: Age and sex differences
Li, C.-L., & Hsu, H.-C. (2015) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2014.10.007 · Cited by 50
Renke, M. B., Marcinkowska, A. B., Kujach, S., & Winklewski, P. J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.803332 · Cited by 50
Kim, W. J., Lee, S. J., Lee, E., Lee, E. Y., & Han, K. (2022) · Diabetes Care · doi:10.2337/dc21-0957 · Cited by 45
Linking chronic kidney disease and Parkinson’s disease: a literature review
Meléndez-Flores, J. D., & Estrada-Bellmann, I. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-020-00623-1 · Cited by 44
Chen, Y.-Y., Wang, M.-C., Wang, Y.-N., Hu, H.-H., Liu, Q.-Q., Liu, H.-J., & Zhao, Y.-Y. (2020) · Biomarker Research · doi:10.1186/s40364-020-00218-z · Cited by 33
Diabetic retinopathy and dementia association, beyond diabetes severity
Lee, C. S., Krakauer, C., Su, Y.-R., Walker, R. L., Blazes, M., McCurry, S. M., Bowen, J. D., McCormick, W. C., Lee, A. Y., Boyko, E. J., et al. (2023) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2022.12.003 · Cited by 25
Metadata
- Authors
- Etgen, T., Chonchol, M., Förstl, H., & Sander, D.
- Venue
- American Journal of Nephrology
- Publisher
- S. Karger AG
- Published
- 2012
- Volume
- 35
- Issue
- 5
- Pages
- 474-482
- ISSN
- 0250-8095 (ISSN-L)
- 1421-9670
- OpenAlex
- W1992332196
- Cited by
- 359
- References
- 32
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.